Synthena AG is a biotechnology company developing new therapies for severe neuromuscular diseases. Its work focuses on RNA modulation and its proprietary tricyclo-DNA technology, including programs related to Duchenne muscular dystrophy.
AI-generated
Comparisons
Synthena AG in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Synthena AG by reviews, experience and specialisations.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.